Hypertension, commonly known as high blood pressure, remains one of the most widespread chronic medical conditions globally, affecting over a billion people and standing as a major risk factor for cardiovascular disease, stroke, and kidney failure. Managing blood pressure requires long-term therapeutic interventions, lifestyle modifications, and reliable pharmaceutical formulations. Among the...

The Cluster Headache Syndrome Market is expected to witness steady growth as the healthcare industry expands access to advanced neurological therapies and improves diagnosis of one of the most severe primary headache disorders. According to Future Market Insights (FMI), the market is projected to grow from USD 1.1 billion in 2026 to USD 1.9 billion by 2036, registering a 5.8% CAGR during the...

NEWARK, Del., USA, JUNE 12, 2025 — According to the latest analysis by Future Market Insights (FMI), the global Cluster Headache Syndrome Market is expected to witness steady growth over the next decade, fueled by increasing awareness of neurological disorders, rising diagnosis rates, growing adoption of targeted biologic therapies, and advancements in neuromodulation technologies. As...

The global pharmaceutical industry continues to witness steady expansion as the prevalence of cardiovascular diseases and hypertension rises across both developed and emerging economies. Nitrendipine, a calcium channel blocker widely prescribed for the management of hypertension and angina, remains an important therapeutic option in cardiovascular care. The drug works by relaxing blood vessels,...